The Effect of the Use of Washing Solutions at Different Temperatures Used in Intra-arterial Cannulation

NCT ID: NCT05911581

Last Updated: 2023-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-16

Study Completion Date

2024-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nowadays, intraarterial catheterization is frequently used as an invasive method for intraoperative blood pressure monitoring and control.The radial artery is frequently used in this procedure and the cannula should be flushed with 2-3 ml of heparinized fluid intermittently to prevent occlusion. During the operation, the ambient temperature is approximately 22-24 C and the patient temperature can be 34-36 C. Since the flushing fluids are also in the environment, they are 22-24 C. The aim of this study is to determine whether the fluids at room temperature cause vasoconstriction in the vessel and cause a change in blood pressure arterial values.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to determine whether room temperature fluids cause vasoconstriction or vasodilatation in the vessel and cause a change in blood pressure arterial values.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrarterial Catheterization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

room temperature washing solution

İntra-arterial flushing with heparinized fluid kept in room air

Group Type ACTIVE_COMPARATOR

intra-arterial flushing

Intervention Type OTHER

The catheter will be flushed to prevent occlusion after radial artery catheterization.

intra-arterial flushing with heparinized fluid kept in room air

washing solution at patient temperature

Intra-arterial flushing with heparinized fluid at patient body temperature

Group Type ACTIVE_COMPARATOR

intra-arterial flushing

Intervention Type OTHER

Intra-arterial flushing with heparinized fluid at patient body temperature

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intra-arterial flushing

The catheter will be flushed to prevent occlusion after radial artery catheterization.

intra-arterial flushing with heparinized fluid kept in room air

Intervention Type OTHER

intra-arterial flushing

Intra-arterial flushing with heparinized fluid at patient body temperature

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

group room group patient

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA I-III risk class,
* Medically undergoing intra-arterial cannulation
* Being between the ages of 18-70

Exclusion Criteria

* Diagnosis of DM
* Vascular disease,
* Bleeding diathesis,
* inotropic drug use
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bursa Yuksek Ihtisas Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Korgün Ökmen

Assoc.Phd.M.D

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bursa Yuksek Ihtisas Training and Research Hospital

Bursa, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Korgün Ökmen, Assoc. PhD.

Role: CONTACT

+905057081021

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/06-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.